Zobrazeno 1 - 10
of 933
pro vyhledávání: '"Almond LM"'
Autor:
Ning J; Certara Predictive Technologies Division, Sheffield, UK., Pansari A; Certara Predictive Technologies Division, Sheffield, UK., Rowland Yeo K; Certara Predictive Technologies Division, Sheffield, UK., Heikkinen AT; Certara Predictive Technologies Division, Sheffield, UK., Waitt C; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.; Infectious Disease Institute, Makerere University College of Health Sciences, Kampala, Uganda.; Royal Liverpool University Hospital, Liverpool, UK., Almond LM; Certara Predictive Technologies Division, Sheffield, UK.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Nov; Vol. 13 (11), pp. 1924-1938. Date of Electronic Publication: 2024 Oct 30.
Autor:
Pansari A; Certara Predictive Technologies Division, Sheffield, UK., Pan X; Certara Predictive Technologies Division, Sheffield, UK., Almond LM; Certara Predictive Technologies Division, Sheffield, UK., Rowland-Yeo K; Certara Predictive Technologies Division, Sheffield, UK.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Nov; Vol. 13 (11), pp. 1841-1855. Date of Electronic Publication: 2024 Sep 16.
Autor:
Morrow AA; University Hospitals Birmingham NHS Trust, Birmingham, UK. anna_a_c@yahoo.com., Hodson J; Research Development and Innovation, Institute of Translational Medicine, University Hospitals Birmingham NHS Trust, Birmingham, UK., Figura C; University Hospitals Birmingham NHS Trust, Birmingham, UK., Bains S; University Hospitals Birmingham NHS Trust, Birmingham, UK., Warner RM; University Hospitals Birmingham NHS Trust, Birmingham, UK., Almond LM; University Hospitals Birmingham NHS Trust, Birmingham, UK.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Jul 01. Date of Electronic Publication: 2024 Jul 01.
Autor:
Abla N; MMV Medicines for Malaria Venture, Geneva, Switzerland., Almond LM; Certara UK Ltd, Sheffield, UK., Bonner JJ; Certara UK Ltd, Sheffield, UK., Richardson N; Magenta Communications Ltd, Abingdon, UK., Wells TNC; MMV Medicines for Malaria Venture, Geneva, Switzerland., Möhrle JJ; MMV Medicines for Malaria Venture, Geneva, Switzerland.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2024 Jul; Vol. 17 (7), pp. e13865.
Autor:
Pan X; Certara UK Limited (Simcyp Division), Sheffield, UK., Abduljalil K; Certara UK Limited (Simcyp Division), Sheffield, UK., Almond LM; Certara UK Limited (Simcyp Division), Sheffield, UK., Pansari A; Certara UK Limited (Simcyp Division), Sheffield, UK., Yeo KR; Certara UK Limited (Simcyp Division), Sheffield, UK.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Mar; Vol. 13 (3), pp. 386-395. Date of Electronic Publication: 2023 Dec 12.
Autor:
Tirotta F; Department of Sarcoma and General Surgery, Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK. Fabio.tirotta@uhb.nhs.uk., Fadel MG; Department of Academic Surgery, Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK., Baia M; Department of Sarcoma and General Surgery, Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.; Sarcoma Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Parente A; Department of Sarcoma and General Surgery, Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Messina V; Department of Sarcoma and General Surgery, Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Bassett P; Statsconsultancy, Amersham, UK., Almond LM; Department of Sarcoma and General Surgery, Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Ford SJ; Department of Sarcoma and General Surgery, Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Desai A; Department of Sarcoma and General Surgery, Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., van Houdt WJ; Department of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Plesmanlaan, Amsterdam, The Netherlands., Strauss DC; Department of Academic Surgery, Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2023 Oct; Vol. 30 (11), pp. 6875-6883. Date of Electronic Publication: 2023 Jul 09.
Autor:
Abla N; Medicines for Malaria Venture, Geneva, Switzerland., Howgate E; Certara UK Ltd, Simcyp Division, Sheffield, UK., Rowland-Yeo K; Certara UK Ltd, Simcyp Division, Sheffield, UK., Dickins M; Certara UK Ltd, Simcyp Division, Sheffield, UK., Bergagnini-Kolev MC; Certara UK Ltd, Simcyp Division, Sheffield, UK., Chen KF; Certara UK Ltd, Simcyp Division, Sheffield, UK., McFeely S; Certara UK Ltd, Simcyp Division, Sheffield, UK., Bonner JJ; Certara UK Ltd, Simcyp Division, Sheffield, UK., Santos LGA; Certara UK Ltd, Simcyp Division, Sheffield, UK., Gobeau N; Medicines for Malaria Venture, Geneva, Switzerland., Burt H; Certara UK Ltd, Simcyp Division, Sheffield, UK., Barter Z; Certara UK Ltd, Simcyp Division, Sheffield, UK., Jones HM; Certara UK Ltd, Simcyp Division, Sheffield, UK., Wesche D; Certara USA, Integrated Drug Development, Grand Rapids, Michigan, USA., Charman SA; Monash University, Melbourne, Victoria, Australia., Möhrle JJ; Medicines for Malaria Venture, Geneva, Switzerland., Burrows JN; Medicines for Malaria Venture, Geneva, Switzerland., Almond LM; Certara UK Ltd, Simcyp Division, Sheffield, UK.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Sep; Vol. 12 (9), pp. 1335-1346. Date of Electronic Publication: 2023 Aug 16.
Autor:
Hong E; Department of Clinical Pharmacy, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, California, Los Angeles, USA., Li R; Department of Clinical Pharmacy, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, California, Los Angeles, USA., Shi A; Department of Clinical Pharmacy, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, California, Los Angeles, USA., Almond LM; Simcyp Division, Certara UK Ltd, Sheffield, UK., Wang J; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.; USC Anton Yelchin CF Clinic, Los Angeles, California, USA., Khudari AZ; Department of Clinical Pharmacy, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, California, Los Angeles, USA., Haddad S; Department of Clinical Pharmacy, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, California, Los Angeles, USA., Sislyan S; Department of Clinical Pharmacy, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, California, Los Angeles, USA., Angelich M; Department of Clinical Pharmacy, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, California, Los Angeles, USA., Chung PS; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.; USC Anton Yelchin CF Clinic, Los Angeles, California, USA., Rao AP; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.; USC Anton Yelchin CF Clinic, Los Angeles, California, USA., Beringer PM; Department of Clinical Pharmacy, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, California, Los Angeles, USA.; USC Anton Yelchin CF Clinic, Los Angeles, California, USA.
Publikováno v:
Pharmacotherapy [Pharmacotherapy] 2023 Apr; Vol. 43 (4), pp. 291-299. Date of Electronic Publication: 2023 Mar 12.
Autor:
Hong E; Department of Clinical Pharmacy, School of Pharmacy, University of Southern Californiagrid.42505.36, Los Angeles, California, USA., Almond LM; Certara UK Ltd., Simcyp Division, Sheffield, United Kingdom., Chung PS; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Keck School of Medicine, University of Southern Californiagrid.42505.36, Los Angeles, California, USA.; USC Anton Yelchin Cystic Fibrosis Clinic, Los Angeles, California, USA., Rao AP; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Keck School of Medicine, University of Southern Californiagrid.42505.36, Los Angeles, California, USA.; USC Anton Yelchin Cystic Fibrosis Clinic, Los Angeles, California, USA., Beringer PM; Department of Clinical Pharmacy, School of Pharmacy, University of Southern Californiagrid.42505.36, Los Angeles, California, USA.; USC Anton Yelchin Cystic Fibrosis Clinic, Los Angeles, California, USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 Nov 15; Vol. 66 (11), pp. e0110422. Date of Electronic Publication: 2022 Oct 26.
Autor:
Tirotta F; Department of Academic Surgery, Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK. f.tirotta@nhs.net.; Department of Sarcoma and General Surgery, Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust, Mindelsohn Way, Birmingham, B15 2TH, UK. f.tirotta@nhs.net., Fadel MG; Department of Academic Surgery, Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK., Hodson J; Institute of Translational Medicine, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.; Research Development and Innovation, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Parente A; Department of Sarcoma and General Surgery, Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust, Mindelsohn Way, Birmingham, B15 2TH, UK., Wilkerson H; Department of Academic Surgery, Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK., Almond LM; Department of Sarcoma and General Surgery, Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust, Mindelsohn Way, Birmingham, B15 2TH, UK., Ford SJ; Department of Sarcoma and General Surgery, Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust, Mindelsohn Way, Birmingham, B15 2TH, UK., Hayes AJ; Department of Academic Surgery, Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK., Desai A; Department of Sarcoma and General Surgery, Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust, Mindelsohn Way, Birmingham, B15 2TH, UK., Strauss DC; Department of Academic Surgery, Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2022 Nov; Vol. 29 (12), pp. 7320-7330. Date of Electronic Publication: 2022 Jul 19.